These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 39182740

  • 21. Spray freeze-drying for inhalation application: process and formulation variables.
    Rostamnezhad M, Jafari H, Moradikhah F, Bahrainian S, Faghihi H, Khalvati R, Bafkary R, Vatanara A.
    Pharm Dev Technol; 2022 Mar; 27(3):251-267. PubMed ID: 34935582
    [Abstract] [Full Text] [Related]

  • 22. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation.
    Maa YF, Ameri M, Shu C, Payne LG, Chen D.
    J Pharm Sci; 2004 Jul; 93(7):1912-23. PubMed ID: 15176078
    [Abstract] [Full Text] [Related]

  • 23. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.
    Saluja V, Amorij JP, Kapteyn JC, de Boer AH, Frijlink HW, Hinrichs WL.
    J Control Release; 2010 Jun 01; 144(2):127-33. PubMed ID: 20219608
    [Abstract] [Full Text] [Related]

  • 24. Spray-freeze-drying of nanosuspensions: the manufacture of insulin particles for needle-free ballistic powder delivery.
    Schiffter H, Condliffe J, Vonhoff S.
    J R Soc Interface; 2010 Aug 06; 7 Suppl 4(Suppl 4):S483-500. PubMed ID: 20519207
    [Abstract] [Full Text] [Related]

  • 25. Inhalable dry powder product (DPP) of mRNA lipid nanoparticles (LNPs) for pulmonary delivery.
    Sarode A, Patel P, Vargas-Montoya N, Allawzi A, Zhilin-Roth A, Karmakar S, Boeglin L, Deng H, Karve S, DeRosa F.
    Drug Deliv Transl Res; 2024 Feb 06; 14(2):360-372. PubMed ID: 37526881
    [Abstract] [Full Text] [Related]

  • 26. Effect of lipid composition on RNA-Lipid nanoparticle properties and their sensitivity to thin-film freezing and drying.
    AboulFotouh K, Southard B, Dao HM, Xu H, Moon C, Williams Iii RO, Cui Z.
    Int J Pharm; 2024 Jan 25; 650():123688. PubMed ID: 38070660
    [Abstract] [Full Text] [Related]

  • 27. Development of Spray-Freeze-Dried Powders for Inhalation with High Inhalation Performance and Antihygroscopic Property.
    Otake H, Okuda T, Okamoto H.
    Chem Pharm Bull (Tokyo); 2016 Jan 25; 64(3):239-45. PubMed ID: 26725381
    [Abstract] [Full Text] [Related]

  • 28. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability.
    Sonner C, Maa YF, Lee G.
    J Pharm Sci; 2002 Oct 25; 91(10):2122-39. PubMed ID: 12226840
    [Abstract] [Full Text] [Related]

  • 29. Continuous freeze-drying of messenger RNA lipid nanoparticles enables storage at higher temperatures.
    Meulewaeter S, Nuytten G, Cheng MHY, De Smedt SC, Cullis PR, De Beer T, Lentacker I, Verbeke R.
    J Control Release; 2023 May 25; 357():149-160. PubMed ID: 36958400
    [Abstract] [Full Text] [Related]

  • 30. Hepatitis-B surface antigen (HBsAg) powder formulation: process and stability assessment.
    Maa YF, Ameri M, Shu C, Zuleger CL, Che J, Osorio JE, Payne LG, Chen D.
    Curr Drug Deliv; 2007 Jan 25; 4(1):57-67. PubMed ID: 17269918
    [Abstract] [Full Text] [Related]

  • 31. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF, Zhao L, Payne LG, Chen D.
    J Pharm Sci; 2003 Feb 25; 92(2):319-32. PubMed ID: 12532382
    [Abstract] [Full Text] [Related]

  • 32. Successful batch and continuous lyophilization of mRNA LNP formulations depend on cryoprotectants and ionizable lipids.
    Lamoot A, Lammens J, De Lombaerde E, Zhong Z, Gontsarik M, Chen Y, De Beer TRM, De Geest BG.
    Biomater Sci; 2023 Jun 13; 11(12):4327-4334. PubMed ID: 37073472
    [Abstract] [Full Text] [Related]

  • 33. Development of a proliposomal pretomanid dry powder inhaler as a novel alternative approach for combating pulmonary tuberculosis.
    Aekwattanaphol N, Das SC, Khadka P, Nakpheng T, Ali Khumaini Mudhar Bintang M, Srichana T.
    Int J Pharm; 2024 Oct 25; 664():124608. PubMed ID: 39163929
    [Abstract] [Full Text] [Related]

  • 34. Protein inhalation powders: spray drying vs spray freeze drying.
    Maa YF, Nguyen PA, Sweeney T, Shire SJ, Hsu CC.
    Pharm Res; 1999 Feb 25; 16(2):249-54. PubMed ID: 10100310
    [Abstract] [Full Text] [Related]

  • 35. 1H NMR quantification of spray dried and spray freeze-dried saccharide carriers in dry powder inhaler formulations.
    Babenko M, Peron JR, Kaialy W, Calabrese G, Alany RG, ElShaer A.
    Int J Pharm; 2019 Jun 10; 564():318-328. PubMed ID: 30890450
    [Abstract] [Full Text] [Related]

  • 36. Tableting behavior of freeze and spray-dried excipients in pharmaceutical formulations.
    Madi C, Hsein H, Busignies V, Tchoreloff P, Mazel V.
    Int J Pharm; 2024 May 10; 656():124059. PubMed ID: 38552753
    [Abstract] [Full Text] [Related]

  • 37. Inhalable Spray-Freeze-Dried Powder with L-Leucine that Delivers Particles Independent of Inspiratory Flow Pattern and Inhalation Device.
    Otake H, Okuda T, Hira D, Kojima H, Shimada Y, Okamoto H.
    Pharm Res; 2016 Apr 10; 33(4):922-31. PubMed ID: 26643921
    [Abstract] [Full Text] [Related]

  • 38. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
    Hufnagel S, Xu H, Sahakijpijarn S, Moon C, Chow LQM, Williams Iii RO, Cui Z.
    Int J Pharm; 2022 Apr 25; 618():121637. PubMed ID: 35259440
    [Abstract] [Full Text] [Related]

  • 39. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
    Babenko M, Alany RG, Calabrese G, Kaialy W, ElShaer A.
    Int J Pharm; 2022 Apr 05; 617():121601. PubMed ID: 35181460
    [Abstract] [Full Text] [Related]

  • 40. Effects of drying method and excipient on the structure and physical stability of protein solids: Freeze drying vs. spray freeze drying.
    Mutukuri TT, Wilson NE, Taylor LS, Topp EM, Zhou QT.
    Int J Pharm; 2021 Feb 01; 594():120169. PubMed ID: 33333176
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.